Download presentation
Presentation is loading. Please wait.
Published byLee Phelps Modified over 9 years ago
1
Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407
2
What do you expect from the medicines that you take?
3
Expect them to work.
4
What do you expect from the medicines that you take? Expect them to work. Expect them to be safe.
5
How does FDA make sure that medicines used in the United States are safe and effective?
6
Regulations based on scientific quality.
7
How does FDA make sure that medicines used in the United States are safe and effective? Regulations based on scientific quality. Inspections based on the regulations.
8
How does FDA make sure that medicines used in the United States are safe and effective? Regulations based on scientific quality. Inspections based on the regulations. Enforcement actions for companies and individuals based on public health law.
9
Safety First The first thing FDA requires is that you show a drug product is safe.
10
Safety First The first thing FDA requires is that you show a drug product is safe. FDA will almost always require that there are animal safety studies done before a new drug can be given to a human.
11
Safety First The first thing FDA requires is that you show a drug product is safe. FDA will almost always require that there are animal safety studies done before a new drug can be given to a human. Animal studies are regulated under the Good Laboratory Practices (GLPs) found in 21 CFR 58
12
Safety First Quality in the GLPs is insured in the following ways:
13
Safety First Quality in the GLPs is insured in the following ways: 1.Facilities that conduct GLP studies must allow FDA to inspect them.
14
Safety First Quality in the GLPs is insured in the following ways: 1.Facilities that conduct GLP studies must allow FDA to inspect them. 2.Each animal facility must have a quality assurance unit that inspects all it studies
15
Safety First Quality in the GLPs is insured in the following ways: 1.Facilities that conduct GLP studies must allow FDA to inspect them. 2.Each animal facility must have a quality assurance unit that inspects all it studies 3.Written protocols are followed by the facility for the conduct of each study
16
Safety First Quality in the GLPs is insured in the following ways: 1.Facilities that conduct GLP studies must allow FDA to inspect them. 2.Each animal facility must have a quality assurance unit that inspects all it studies 3.Written protocols are followed by the facility for the conduct of each study 4.Equipment used in each study is validated for use in the study prior to the start of the study
17
Safety First: On to humans Before FDA will allow use of a new drug in human studies you must file an Investigational New Drug (IND) application for their review.
18
Safety First: On to humans Before FDA will allow use of a new drug in human studies you must file an Investigational New Drug (IND) application for their review. INDs contain: The clinical protocol that is intend for use in humans
19
Safety First: On to humans Before FDA will allow use of a new drug in human studies you must file an Investigational New Drug (IND) application for their review. INDs contain: The clinical protocol that is intend for use in humans Animal Safety Data
20
Safety First: On to humans Before FDA will allow use of a new drug in human studies you must file an Investigational New Drug (IND) application for their review. INDs contain: The clinical protocol that is intend for use in humans Animal Safety Data Drug product manufacturing information
21
Safety First: On to humans Before FDA will allow use of a new drug in human studies you must file an Investigational New Drug (IND) application for their review. INDs contain: The clinical protocol that is intend for use in humans Animal Safety Data Drug product manufacturing information All references intended to support the application
22
INDs What does FDA expect you to know about a new drug that is going to be used in Humans?
23
INDs What does FDA expect you to know about a new drug that is going to be used in Humans? Identity
24
INDs What does FDA expect you to know about a new drug that is going to be used in Humans? Identity Strength
25
INDs What does FDA expect you to know about a new drug that is going to be used in Humans? Identity Strength Potency
26
INDs What does FDA expect you to know about a new drug that is going to be used in Humans? Identity Strength Potency Purity
27
INDs What does FDA expect you to know about a new drug that is going to be used in Humans? Identity Strength Potency Purity Quality
28
INDs What does FDA expect you to know about a new drug that is going to be used in Humans? Identity Strength Potency Purity Quality Everything!
29
GMPs You know everything about a investigational drug product based on the Good Manufacturing Practice Regulations (cGMPs) found in 21 CFR 210 & 211
30
GMPs The GMPs: Define the responsibilities of a companies Quality Control Unit
31
GMPs The GMPs: Define the responsibilities of a companies Quality Control Unit Define the minimum qualifications for QA personnel
32
GMPs The GMPs: Define the responsibilities of a companies Quality Control Unit Define the minimum qualifications for QA personnel Define the minimum specifications for facilities and equipment
33
GMPs The GMPs: Define the responsibilities of a companies Quality Control Unit Define the minimum qualifications for QA personnel Define the minimum specifications for facilities and equipment Provide requirements for control of components and products
34
GMPs The GMPs: Define the responsibilities of a companies Quality Control Unit Define the minimum qualifications for QA personnel Define the minimum specifications for facilities and equipment Provide requirements for control of components and products Provide for controls on processing, production, packaging, labeling, holding, and distribution of drug product
35
GMPs The GMPs: Define the responsibilities of a companies Quality Control Unit Define the minimum qualifications for QA personnel Define the minimum specifications for facilities and equipment Provide requirements for control of components and products Provide for controls on processing, production, packaging, labeling, holding, and distribution of drug product Also provides minimum requirements for laboratory controls, records and reports
36
But does it work?
37
Phase II clinical trials involve drugs that have successfully completed safety testing and start to look and see if a drug is effective and why it is effective.
38
But does it work? Phase II clinical trials involve drugs that have successfully completed safety testing and start to look and see if a drug is effective and why it is effective. Phase III clinical trials use all the information found in the earlier phases and expand it to large numbers of subjects in different locations to verify that the data is still the same.
39
Marketing a drug After you have completed the Phase III trials you can file for marketing clearance with FDA in order to be able to sell the drug.
40
Marketing a drug After you have completed the Phase III trials you can file for marketing clearance with FDA in order to be able to sell the drug. Quality doesn’t stop there! FDA requires “post-marketing” studies usually called Phase IV studies that are on going as long as the drug is on the market.
41
Questions:
42
Quality Workshop Quality By Design:
43
What is QbD?
44
FDA push to improve the drug development process
45
What is QbD? FDA push to improve the drug development process Seeks to reduce the cost of product development due to low efficiencies, waste, and manufacturing time requirements due to testing
46
What is QbD? FDA push to improve the drug development process Seeks to reduce the cost of product development due to low efficiencies, waste, and manufacturing time requirements due to testing FDA states that you can’t test quality into a product, it must be designed there
47
What is QbD? A scientific, risk-based, holistic and proactive approach to pharmaceutical development.
48
What is QbD? A scientific, risk-based, holistic and proactive approach to pharmaceutical development. A deliberate design effort from product conception through commercialization.
49
What is QbD? A scientific, risk-based, holistic and proactive approach to pharmaceutical development. A deliberate design effort from product conception through commercialization. Manufacturer’s should have a full understanding of how product attributes and process relate to product performance
50
QbD System
51
Better View
52
Another Flow Chart
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.